Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10953101 Glycotargeting therapeutics

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 19, 2018
Date of Patent
March 23, 2021
Patent Application Number
15925628
Patent Citations
‌
US Patent 10046056 Glycotargeting therapeutics
Patent Citations Received
‌
US Patent 11666638 Glycotargeting therapeutics
0
‌
US Patent 11801305 Glycotargeting therapeutics
‌
US Patent 11253579 Compositions and methods for inducing immune tolerance
0
‌
US Patent 11654188 Glycotargeting therapeutics
0
‌
US Patent 11246943 Antigen-specific tolerance and compositions for induction of same
Patent Inventor Names
Jeffrey A. Hubbell
0
David Scott Wilson
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10953101
Patent Primary Examiner
‌
Thea D' Ambrosio

Find more entities like US Patent 10953101 Glycotargeting therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo